Tata Institute comes up with a ₹100 drug to prevent cancer recurrence
Researchers at the Tata Institute in Mumbai announced the development of a novel drug aimed at preventing cancer recurrence, according to a report by Hindustan Times. The researchers and doctors at the institute have reportedly worked for 10 years and have now come up with a tablet which they claimed would stop the occurrence of…
